Celltrion, Inc.

068270.KS · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

124,932 KRW (≈ 87.45 USD)

Margin of Safety

-38.6 %

Rating

BEOBACHTEN

Celltrion develops, manufactures, and markets biosimilars and innovative biologics—particularly monoclonal antibodies—and generates revenue primarily through the sale of these products to global pharmaceutical wholesalers, hospitals, and healthcare systems, with regulatory approvals securing market access.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.